Figure 2. The therapeutic response of galantamine concentration in Alzheimer’s disease.
The adjusted effects of the concentration of galantamine in each cognitive domain to individualized therapeutic response in Alzheimer’s disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.